IP Library Patent Application 14560053
Patent Application
App. No. 14/560,053

DELIVERY OF GASES TO THE NASAL AIRWAY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/560,053
Abstract

A delivery device for and a method of delivering gases to the nasal airway, in particular therapeutic gases and gases in combination with active substances, either as powders or liquids, for enhanced uptake of the active substances.

Claims (11)

1 . A delivery device for providing a therapeutic gas to the nasal airway of a subject, the delivery device comprising:

a nosepiece for fitting to one nostril of the subject;

a mouthpiece through which the subject in use exhales and which is fluidly connected to the nosepiece; and

a scrubber which is operative at least to reduce the concentration of at least one gas from an exhaled breath of the subject as delivered through the mouthpiece and provide a gas flow to the nosepiece which has an increased concentration of at least one other, therapeutic gas which provides a therapeutic effect.

2 . The delivery device of claim 1 , wherein the scrubber is operative to reduce the concentration of at least two gases from an exhaled breath of the subject.

3 . The delivery device of claim 1 , wherein the at least one gas comprises nitrogen.

4 . The delivery device of claim 1 , wherein the at least one gas comprises oxygen.

5 . The delivery device of claim 1 , wherein the at least one other, therapeutic gas comprises oxygen.

6 . The delivery device of claim 1 , wherein the at least one gas comprises carbon dioxide.

7 . The delivery device of claim 1 , wherein the at least one other, therapeutic gas comprises carbon dioxide.

8 . The delivery device of claim 1 , wherein the scrubber is operative to provide a gas flow which has a concentration of the at least one other, therapeutic gas of at least 10 vol %, optionally at least 15 vol %, optionally at least 20 vol %, optionally at least 30 vol %, optionally at least 40 vol %, and optionally at least 50 vol %.

Assignments (3)
RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 Recorded Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
SECURITY INTEREST Recorded Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: DJUPESLAND, PER GISLE; HAFNER, RODERICK PETER
To: OPTINOSE AS
Reel/Frame 042707/0813 →